MARINUS PHARMACEUTICALS INC (MRNS)
US56854Q2003 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 15.35M 792.44% | 25.48M 65.99% | 30.989M 21.62% | 35.297M 13.90% | 50.826M 44.00% | 60.103M 18.25% | 104.63M 74.08% | 155.36M 48.49% | 184.89M 19.01% | 181.57M -1.80% | 202.18M 11.35% | |
| EBITDA YoY % growth | -95.09M -40.64% | -112.37M -18.17% | -130.934M -16.52% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -95.45M -40.49% | -112.79M -18.17% | -131.485M -16.58% | -106.772M 18.80% | -30.122M 71.79% | -27.437M 8.91% | 15.585M 156.80% | 67.729M 334.58% | 89.382M 31.97% | 82.885M -7.27% | 103.49M 24.86% | |
| Operating Margin | -621.82% | -442.66% | -424.30% | -302.50% | -59.26% | -45.65% | 14.90% | 43.59% | 48.34% | 45.65% | 51.19% | |
| EPS YoY % growth | -2.69 -4.26% | -3.28 -21.93% | -2.63 19.82% | -2.06 21.60% | -0.58 72.01% | -0.31 46.97% | 0.13 142.23% | 0.82 534.02% | 1.48 81.13% | 1.06 -28.52% | 1.24 16.83% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.30 59.70% | -0.20 70.75% | -0.17 71.10% | -0.13 68.43% | -0.07 76.91% |
| Revenue Q2Q % growth | 10.685M 48.61% | 9.848M 28.25% | 11.021M 36.80% | 12.041M 40.98% | 16.295M 52.50% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -15.585M 56.02% | -10.797M 69.86% | -8.895M 70.63% | -7.866M 62.68% | -4.482M 71.24% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.42 31.15% | -0.42 | 0.00 | -0.53% |
| Q2 2024 Q2Q % growth | -0.60 1.64% | -0.60 | 0.00 | 0.22% |
| Q1 2024 Q2Q % growth | -0.68 -1.49% | -0.67 | -0.01 | -0.79% |
| Q4 2023 Q2Q % growth | -0.74 2.63% | -0.64 | -0.10 | -16.47% |
| Q3 2023 Q2Q % growth | -0.61 35.11% | -0.67 | 0.06 | 9.48% |
| Q2 2023 Q2Q % growth | -0.61 42.45% | -0.73 | 0.12 | 16.56% |
| Q1 2023 Q2Q % growth | -0.67 -28.85% | -0.74 | 0.07 | 9.13% |
| Q4 2022 Q2Q % growth | -0.76 1.30% | -0.71 | -0.05 | -6.95% |
| Q3 2022 Q2Q % growth | -0.94 -77.36% | 0.48 | -1.42 | -297.29% |
| Q2 2022 Q2Q % growth | -1.06 -63.08% | -0.70 | -0.36 | -51.67% |
| Q1 2022 Q2Q % growth | -0.52 29.73% | -0.87 | 0.35 | 40.02% |
| Q4 2021 Q2Q % growth | -0.77 -40.00% | -0.78 | 0.01 | 0.83% |
| Q3 2021 Q2Q % growth | -0.53 -3.92% | -0.75 | 0.22 | 29.05% |
| Q2 2021 Q2Q % growth | -0.65 -1.56% | -0.70 | 0.05 | 7.20% |
| Q1 2021 Q2Q % growth | -0.74 15.91% | -0.46 | -0.28 | -60.71% |
| Q4 2020 Q2Q % growth | -0.55 45.00% | -0.52 | -0.03 | -6.42% |
| Q3 2020 Q2Q % growth | -0.51 50.96% | -0.61 | 0.10 | 16.68% |
| Q2 2020 Q2Q % growth | -0.64 33.33% | -0.77 | 0.13 | 16.46% |
| Q1 2020 Q2Q % growth | -0.88 8.33% | -0.65 | -0.23 | -35.75% |
| Q4 2019 Q2Q % growth | -1.00 | -0.85 | -0.15 | -17.51% |
| Q3 2019 Q2Q % growth | -1.04 | -0.97 | -0.07 | -7.49% |
| Q2 2019 Q2Q % growth | -0.96 | -0.97 | 0.01 | 1.37% |
| Q1 2019 Q2Q % growth | -0.96 | -0.88 | -0.08 | -9.44% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 8.541M 16.39% | 9.606M | -1.065M | -11.09% |
| Q2 2024 Q2Q % growth | 8.056M 32.48% | 9.685M | -1.629M | -16.82% |
| Q1 2024 Q2Q % growth | 7.679M -26.02% | 9.308M | -1.629M | -17.50% |
| Q4 2023 Q2Q % growth | 7.19M 0.42% | 8.175M | -985K | -12.05% |
| Q3 2023 Q2Q % growth | 7.338M 213.59% | 6.458M | 880K | 13.63% |
| Q2 2023 Q2Q % growth | 6.081M 239.72% | 5.849M | 232K | 3.97% |
| Q1 2023 Q2Q % growth | 10.38M -26.85% | 5.999M | 4.381M | 73.03% |
| Q4 2022 Q2Q % growth | 7.16M 371.05% | 5.459M | 1.701M | 31.16% |
| Q3 2022 Q2Q % growth | 2.34M -76.85% | 30.066M | -27.726M | -92.22% |
| Q2 2022 Q2Q % growth | 1.79M -6.28% | 2.361M | -571K | -24.18% |
| Q1 2022 Q2Q % growth | 14.19M 683.98% | 2.322M | 11.868M | 511.11% |
| Q4 2021 Q2Q % growth | 1.52M -1.94% | 3.434M | -1.914M | -55.74% |
| Q3 2021 Q2Q % growth | 10.11M 5,847.06% | 2.218M | 7.892M | 355.82% |
| Q2 2021 Q2Q % growth | 1.91M | 2.787M | -877K | -31.47% |
| Q1 2021 Q2Q % growth | 1.81M | 2.617M | -807K | -30.84% |
| Q4 2020 Q2Q % growth | 1.55M | 1.06M | 490K | 46.23% |
| Q3 2020 Q2Q % growth | 170K | 433.5K | -263.5K | -60.78% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 45% | 0.05% | -6.29% |
| Revenue | 0% | -10.45% | -1.56% | -6% |